Search

News & Events

Perth researchers are about to trial a new vaccine that aims to protect against all four strains of the potentially devastating Dengue Fever.

News & Events

High rates of recurrent infection are a major risk to the health of Aboriginal children and are comparable to those of third world countries.

Research

Jonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@

Research

We identified the existence of more than 290 clinically associated genomic phylogroups across 22 countries, highlighting challenges in designing vaccines of global utility

Research

Here, the role, status, and directions in Group A Streptococcus vaccines research are discussed

Research

We review GAS transmission characteristics and prevention strategies, historical and geographical trends and report on the estimated global burden disease...

Research

In Australia, rheumatic heart disease (RHD) is almost exclusively restricted to Aboriginal Australian and Torres Strait Islander people with children being...

Research

Globally, ARF and RHD cause more than a quarter of a million deaths and substantial disability each year.

Research

Concerns regarding adverse events following immunisation are a barrier to vaccine uptake. Health professionals use vaccine safety surveillance systems (VSSS) to monitor vaccines and inform the public of safety data. With little known about public attitudes, perceptions, and experiences with VSSS, we examined them in the context of COVID-19 vaccinations in Western Australia.

Research

Despite universal access to government-funded direct-acting antivirals in 2016, the rate of hepatitis C treatment uptake in Australia has declined substantially. Most hepatitis C is related to injecting drug use; reducing the hepatitis C burden among people who inject drugs is, therefore, paramount to reach hepatitis C elimination targets.